Glucagon-like peptide 1 receptor agonists in heart failure: the need for a rewind

Autores da FMUP

• João Pedro Melo Marques Pinho Ferreira

  Autor

• João Sérgio De Lima Soares Neves

  Autor

Unidades de investigação

• Cirurgia e Fisiologia

• Laboratório Associado RISE- Rede de Investigação em Saúde

  

  Investigador

  Fernando Carlos De Landér Schmitt

• RISE-Health

  

  Investigador

  Fernando Carlos De Landér Schmitt

Abstract

[No abstract available]

Keywords

• Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Heart Failure; Humans; Hypoglycemic Agents; cyclic AMP; dulaglutide; glucagon like peptide 1 receptor agonist; liraglutide; tirzepatide; antidiabetic agent; glucagon like peptide 1; glucagon like peptide 1 receptor; cardiovascular disease; cardiovascular mortality; echocardiography; Editorial; follow up; heart failure; heart failure with preserved ejection fraction; heart failure with reduced ejection fraction; heart rate; hospitalization; human; mortality; New York Heart Association class; non insulin dependent diabetes mellitus; obesity; percutaneous coronary intervention; randomized controlled trial (topic); cardiovascular disease; heart failure; non insulin dependent diabetes mellitus